Ibogaine, a psychoactive compound extracted from the African Tabernanthe iboga plant, has gained attention for its potential to disrupt addictive …
MindMed Advances 18-MC, Potential Treatment for Opioid Addiction, Into Further Clinical Testing
18-MC is a proprietary, non-hallucinogenic molecule, based on the psychedelic ibogaine. In extensive nonclinical testing, 18-MC has shown promise …